Nichole Coleman is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of medical therapeutics, particularly in the development of methods for treating seizure disorders and pain. With a total of 2 patents, her work is paving the way for innovative treatments that can improve the quality of life for many patients.

Latest Patents

Nichole Coleman's latest patents include "Selective activators of the intermediate conductance CA2+activated K+ channel KCa3.1 and their methods of use." This patent focuses on benzoxazole and indole type KCa3.1 activators, detailing their therapeutic uses in human or animal subjects, as well as their application in the ex vivo preservation of organs or tissues. Another significant patent is "Methods for treating seizure disorders and pain," which provides methods for treating seizure disorders through the administration of 2-amino-6-trifluoromethylthio-benzothiazole, or a pharmaceutically acceptable salt thereof. This invention also describes methods for the treatment of pain.

Career Highlights

Nichole Coleman is affiliated with the University of California, where she continues her research and development in medical therapeutics. Her work is characterized by a commitment to advancing healthcare solutions through innovative inventions.

Collaborations

Throughout her career, Nichole has collaborated with notable colleagues, including Heike Wulff and Brandon M Brown. These partnerships have contributed to the success and impact of her research.

Conclusion

Nichole Coleman is a trailblazer in the field of medical therapeutics, with her innovative patents addressing critical health issues. Her contributions are essential in the ongoing quest for effective treatments for seizure disorders and pain management.